Signaturefd, LLC Halozyme Therapeutics, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 1,046 shares of HALO stock, worth $55,228. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,046

Previous 1,046 -0.0%

Holding current value

$55,228

Previous $54,000 9.26%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$37.81 - $52.4 $983 - $1,362	-26 Reduced 2.43%	1,046 $54,000
Q1 2024 May 03, 2024	SELL	$33.68 - $41.95 $2,795 - $3,481	-83 Reduced 7.19%	1,072 $43,000
Q4 2023 Jan 31, 2024	SELL	$33.32 - $42.1 $533 - $673	-16 Reduced 1.37%	1,155 $42,000
Q3 2023 Nov 03, 2023	SELL	$36.46 - $44.03 $1,604 - $1,937	-44 Reduced 3.62%	1,171 $44,000
Q2 2023 Aug 01, 2023	BUY	$30.28 - $38.74 $16,290 - $20,842	538 Added 79.47%	1,215 $43,000
Q1 2023 Apr 28, 2023	SELL	$32.86 - $55.7 $1,248 - $2,116	-38 Reduced 5.31%	677 $25,000
Q4 2022 Jan 27, 2023	BUY	$40.06 - $59.44 $1,962 - $2,912	49 Added 7.36%	715 $40,000
Q3 2022 Nov 08, 2022	SELL	$38.53 - $51.78 $3,159 - $4,245	-82 Reduced 10.96%	666 $26,000
Q2 2022 Aug 10, 2022	BUY	$37.35 - $48.3 $1,195 - $1,545	32 Added 4.47%	748 $33,000
Q1 2022 May 02, 2022	BUY	$31.97 - $41.06 $4,347 - $5,584	136 Added 23.45%	716 $29,000
Q4 2021 Jan 25, 2022	BUY	$31.82 - $40.75 $1,113 - $1,426	35 Added 6.42%	580 $23,000
Q3 2021 Oct 28, 2021	SELL	$38.47 - $46.42 $3,116 - $3,760	-81 Reduced 12.94%	545 $22,000
Q2 2021 Jul 26, 2021	BUY	$38.84 - $51.31 $2,058 - $2,719	53 Added 9.25%	626 $28,000
Q1 2021 Apr 30, 2021	BUY	$39.51 - $51.45 $1,580 - $2,058	40 Added 7.5%	573 $24,000
Q3 2020 Nov 03, 2020	BUY	$25.74 - $29.63 $746 - $859	29 Added 5.75%	533 $14,000
Q2 2020 Jul 30, 2020	BUY	$16.25 - $26.81 $4,078 - $6,729	251 Added 99.21%	504 $14,000
Q1 2020 Apr 23, 2020	BUY	$13.9 - $21.83 $2,835 - $4,453	204 Added 416.33%	253 $5,000
Q2 2019 Jul 31, 2019	BUY	$14.75 - $17.26 $722 - $845	49 New	49 $1,000

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account